Codexis gains US patent for biocatalysts, biocatalytic processes
The 20-year term patent titled, Biocatalytic Processes For The Preparation Of Substantially Stereomerically Pure Fused Bicyclic Proline Compounds, does not expire until 2029. Codexis senior vice president Peter
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.